胰腺癌全新型辅助治疗后局部区域复发模式及对最佳新辅助放疗靶区体积的启示
本研究旨在绘制胰腺导管腺癌(PDAC)患者接受新辅助化疗和放疗(全新型辅助治疗[TNT])后手术切除的局部复发图谱。2009年至2022年间经TNT后手术治疗的局部区域复发被影像学识别并勾画,创建涵盖所有患者、仅胰头、仅胰体/尾80%复发的阈值轮廓。多数复发部分位于已发表勾画指南或血管体积扩展野内,体积覆盖率低,常见复发区域包括主动脉膈肌交界、胰后十二指肠淋巴结区及肠系膜上动脉右侧区域。作者设计了新的新辅助轮廓以覆盖最中央80%的复发。
要点
- TNT后PDAC局部区域复发罕见,80例可评估复发患者中多数复发部分位于现有勾画指南或血管体积扩展野内,体积覆盖率低。
- 常见复发区域包括主动脉膈肌交界、胰后十二指肠淋巴结区和肠系膜上动脉右侧区域。
- 作者提出的新辅助轮廓可覆盖最中央80%的复发,有助于确保高危区域的最佳覆盖。
核心结论
- 这是迄今最大规模仅接受TNT治疗的PDAC患者局部/区域复发集合。
- TNT治疗的PDAC局部/区域复发模式与手术优先治疗的PDAC患者显著不同。
- 本研究提出的新勾画指南有助于确保高危区域的最佳覆盖,并避免依赖当前辅助指南指导治疗计划。
研究设计与样本
- 回顾性分析2009年至2022年间接受TNT后手术治疗的PDAC患者的局部区域复发。
- 查询了474例接受TNT治疗的PDAC患者数据库,识别出80例孤立局部区域复发或同时局部和远处复发患者。
- 使用MIM软件对复发进行个体化勾画并汇总至单一基准扫描,创建涵盖所有患者、仅胰头、仅胰体/尾80%复发的阈值轮廓。
- 测量危及器官与阈值轮廓间距离以设计最佳临床靶区轮廓,并将复发模式与现有辅助指南比较以评估覆盖。
主要发现
- 在该队列中局部区域复发罕见。
- 80例患者被识别为孤立局部区域复发或同时局部和远处复发。
- 多数复发部分位于已发表勾画指南的轮廓内或血管体积扩展野内,所有体积覆盖率均低。
- 常见复发区域包括主动脉膈肌交界、胰后十二指肠淋巴结区和肠系膜上动脉右侧区域。
- 设计了新的新辅助轮廓以覆盖最中央80%的复发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to generate a map of local recurrences after neoadjuvant chemotherapy and radiation (total neoadjuvant therapy [TNT]) followed by surgical resection for pancreatic ductal adenocarcinoma (PDAC). Such recurrence patterns will serve to inform radiation treatment planning volumes that should be given in the neoadjuvant setting. METHODS AND MATERIALS: Locoregional recurrences after TNT followed by surgery treated between 2009 and 2022 were radiologically identified. Recurrences were individually segmented using MIM software and complied in a single base scan. All contour compilations were used to create a threshold contour encompassing 80% of recurrences among all patients, head only, and body/tail only. The distance between organs at risk and the threshold contour were measured to design an optimal clinical target volume contour for patients treated with TNT. Recurrence patterns were also compared with existing adjuvant guidelines to assess coverage. RESULTS: A database of 474 patients managed with TNT for PDAC was queried. While locoregional recurrences were rare in this cohort, we identified 80 patients with either isolated locoregional or simultaneous local and distant recurrences. Patients with diagnostic imaging at the time of recurrence were identified. The majority of recurrences were partially in the field of published contouring guidelines or volumetric expansions off of vessels, and volumetric coverage was low for all. Common areas of recurrence include the aorticodiaphragmatic junction, retropancreatic duodenal nodal basin, and the region to the right of the superior mesenteric artery. A novel set of proposed neoadjuvant contours was designed to cover the central-most 80% of recurrences. CONCLUSIONS: This is the largest collection of local/regional PDAC recurrences from a cohort of patients treated exclusively with TNT. Patterns of local/regional recurrence using TNT in PDAC vary significantly from those patients with PDAC treated with a surgery-first approach. Novel contouring guidelines presented in this study can help to ensure optimal coverage of high risk regions and avoid reliance on the current adjuvant guidelines to guide treatment planning.
引用
- Beltran Ponce SE, Small CJ, Ahmad T, et al. Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. Pract Radiat Oncol. 2024. PMID: 39182645. doi:10.1016/j.prro.2024.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。